Reishi Side Effects, Doses and Interactions

Of all the mushrooms that turn up in coffee blends, reishi is the one to actually pay attention to.

Not because it is dangerous. Because it is the only one in the category with a documented, dose-dependent pharmacological effect that interacts with a common class of medication, and because it is the one most often sold for sleep, which means people take it every night without thinking of it as a drug.

Ganoderma lucidum is not a culinary mushroom. It is a hard, varnished, bitter bracket fungus that has always been prepared as a concentrated decoction or extract. Treating it like a food is the category error worth avoiding.

The interaction that matters: anticoagulants

This is the headline, and the useful part is that it comes with a number.

Reishi appears to reduce platelet aggregation, an effect attributed to its ganoderic acids, the triterpene compounds responsible for its bitterness. The effect is dose-dependent, and the threshold is specific enough to be practically useful: around 1.5 g per day has not been found to reduce platelet aggregation, while about 3 g per day has.

There is also human case evidence. A patient on warfarin therapy showed markedly elevated INR values, in the range of 6.9 and 8.2, correlating on two separate occasions with taking two 500 mg tablets of Ganoderma lucidum extract^[2]. Case reports are the weakest form of clinical evidence and also the form that catches interactions first, and an INR in that range is a genuine bleeding risk rather than a laboratory curiosity.

What this means at coffee doses. A multi-mushroom blend declaring a few hundred milligrams of total mushroom material, split across four to six species, contains a small fraction of even the 1.5 g that showed no measurable effect. So the honest framing is not "mushroom coffee thins your blood." It is that reishi has a real dose-dependent antiplatelet effect, that a reishi supplement can plausibly reach the relevant range and a coffee sachet almost certainly cannot, and that neither is something to start silently while on warfarin, a DOAC, or daily aspirin.

If you take any of those, mention it. The conversation costs nothing.

Before surgery

The one piece of unambiguous practical advice here.

Because of the platelet effect, the standard precaution for medicinal mushroom supplements is to stop roughly two weeks before scheduled surgery and to tell your surgical team what you have been taking, including a coffee blend.

Do not make the judgement yourself that a sachet is too small to matter. Surgical teams ask about supplements for exactly this reason and they are better placed to decide.

Immunosuppressants

The second interaction worth raising, and it follows from why reishi is sold at all.

Reishi's beta-glucans and polysaccharides are studied specifically for immune modulation^[7]. If you take a medication whose purpose is to suppress immune function, after a transplant or for an autoimmune condition, adding a supplement researched for the opposite effect is a legitimate question.

This is not a hypothetical constructed to fill a safety section. It is the mechanism the product is marketed on, applied in the other direction.

What the trials reported

Reishi has better clinical literature than most of this category, which means the side effect picture is unusually well described for a supplement ingredient.

A 2005 randomised, double-blind, placebo-controlled trial of a Ganoderma lucidum polysaccharide extract in neurasthenia ran for eight weeks and reported improvements in fatigue and wellbeing^[4]. A pilot trial gave reishi spore powder at 1 g three times daily to breast cancer patients on endocrine therapy^[5].

Across the trial literature, comprehensive safety reviews describe reishi as generally well tolerated at studied doses, with adverse effects that are mild and predominantly digestive: dry mouth, nausea, loose stools, stomach discomfort^[1][3].

Two things worth adding for balance. Cochrane's systematic review of reishi for cancer treatment concluded the evidence did not support it as a first-line therapy, and noted the limited quality of the available trials^[6]. And a 2008 report examined toxicity of Ganoderma lucidum in children with cancer, which is a reminder that the populations most likely to reach for reishi are often the ones with the least margin for an unexpected interaction.

The liver question

"Reishi liver" is a recurring search, so it deserves a direct answer rather than a hedge.

There is no established pattern of reishi causing liver injury at normal doses. Comprehensive safety reviews covering its toxicological properties do not describe hepatotoxicity as a characteristic effect^[1][2].

Isolated case reports involving mushroom powder products do exist, as they do for a long list of botanicals, and the standard confounders apply in nearly all of them: the product identity is unverified, contamination or adulteration cannot be excluded, and concurrent medications are usually present. A case report of harm after taking an unverified powder is evidence about that powder as much as about the species.

The practical position: reishi is not known to be hepatotoxic, and if you have existing liver disease you should clear any concentrated botanical extract with a clinician rather than assume it is benign. That applies to reishi no more and no less than to most of the supplement aisle.

Pregnancy and breastfeeding

Reishi is commonly advised against in pregnancy, and it is worth being precise about why, because the reason shapes how seriously to take it.

It is not that reishi is known to harm a pregnancy. It is that reishi has not been studied in pregnancy at supplement doses, and it is a concentrated extract with documented immune activity and a documented dose-dependent platelet effect. Absent data plus known pharmacological activity is a reasonable basis for caution, and it is a different statement from a demonstrated risk.

Breastfeeding is the same picture: unstudied, so unresolved.

For mushroom coffee specifically, the caffeine question is separate, has clear guidance, and is covered in our general side effects guide.

Who should not take reishi without asking first

• Anyone on anticoagulants or antiplatelet drugs. Warfarin, DOACs, daily aspirin, clopidogrel. The clearest concern in this article.
• Anyone on immunosuppressants, or post-transplant.
• Anyone with a scheduled surgery. Stop about two weeks before and disclose it.
• Anyone pregnant or breastfeeding. Unstudied.
• Anyone with a bleeding disorder or unexplained bruising.
• Anyone with existing liver disease, as a general precaution for concentrated botanical extracts rather than a reishi-specific finding.
• Anyone with a mushroom allergy.

The short version

Reishi is well tolerated at the doses studied, and its side effects are mild and digestive. The reason it heads the caution list for this whole category is not its side effects but its interactions: a real, dose-dependent antiplatelet effect appearing around 3 g per day and not around 1.5 g, one published warfarin case with a dangerous INR, and immune activity that cuts against immunosuppressive therapy.

At coffee-sachet doses all of that is much smaller, and "much smaller" is not "discuss with nobody" when you are on a blood thinner. If you take reishi as a standalone supplement rather than as a fraction of a coffee blend, you are in the range where these findings were made, and you should treat it accordingly.